A potential new approach for the treatment of schizophrenia

By: Vanderbilt University Research News

Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

by; Vanderbilt Research news

New Dystonia Drug Candidates Discovered

by: Dystonia Medical Research Foundation

Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

by: Research News @ Vanderbilt University

Soleno Therapeutics announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K (ATP) Channel Activators for the Treatment of Rare Diseases.

by: Soleno Therapeutics